Hereditary Hypertension: Difference between revisions
(Created page with "{{subst:New Page}}") |
No edit summary |
||
| Line 1: | Line 1: | ||
<div class="editorbox"> | <div class="editorbox"> | ||
'''Original Editor '''- [[User: | '''Original Editor '''- [[User:Lucinda hampton|Lucinda hampton ]] | ||
'''Top Contributors''' - {{Special:Contributors/{{FULLPAGENAME}}}} | '''Top Contributors''' - {{Special:Contributors/{{FULLPAGENAME}}}} | ||
</div> | </div> | ||
== Introduction == | == Introduction == | ||
Hypertension (HPT) is known to be a complex heterogeneous condition controlled by many genes. The factors that regulate HPT have a strong genetic component, but the precise genes involved in HTN development are not well known. The drug therapy available for HPT do not always prevent the occurrence of high BP. Novel drug treatment approaches are needed that use genetic approaches and personalized medicine. | |||
== Sub Heading 2 == | == Sub Heading 2 == | ||
| Line 21: | Line 22: | ||
<references /> | <references /> | ||
[[Category:Cardiovascular Disease - Interventions]] | |||
[[Category:Cardiovascular Disease]] | |||
[[Category:Global Health]] | |||
[[Category:Pharmacology for Cardiovascular Disease]] | |||
Revision as of 02:47, 7 May 2024
Original Editor - Lucinda hampton
Top Contributors - Lucinda hampton
Introduction[edit | edit source]
Hypertension (HPT) is known to be a complex heterogeneous condition controlled by many genes. The factors that regulate HPT have a strong genetic component, but the precise genes involved in HTN development are not well known. The drug therapy available for HPT do not always prevent the occurrence of high BP. Novel drug treatment approaches are needed that use genetic approaches and personalized medicine.
Sub Heading 2[edit | edit source]
Sub Heading 3[edit | edit source]
Resources[edit | edit source]
- bulleted list
- x
or
- numbered list
- x
